See more : Sonova Holding AG (0QPY.L) Income Statement Analysis – Financial Results
Complete financial analysis of Jointown Pharmaceutical Group Co., Ltd (600998.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jointown Pharmaceutical Group Co., Ltd, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Hung Ching Development & Construction Co., Ltd. (2527.TW) Income Statement Analysis – Financial Results
- SNDL Inc. (SNDL) Income Statement Analysis – Financial Results
- Siemens Energy AG (SMNEY) Income Statement Analysis – Financial Results
- Prime US REIT (OXMU.SI) Income Statement Analysis – Financial Results
- Mirvac Group (MGR.AX) Income Statement Analysis – Financial Results
Jointown Pharmaceutical Group Co., Ltd (600998.SS)
About Jointown Pharmaceutical Group Co., Ltd
Jointown Pharmaceutical Group Co., Ltd provides marketing, distribution, and logistics services for digital pharmaceutical businesses. It wholesales Chinese herbal medicines, Chinese patent medicines, chemical medicinal materials, chemical medicine preparations, antibiotic preparations, biochemical drugs, biological products, chemical raw materials, and medical toxic drugs. The company was founded in 1999 and is based in Wuhan, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 150.14B | 140.42B | 122.41B | 110.86B | 99.50B | 87.14B | 73.94B | 61.56B | 49.59B | 41.07B | 33.44B | 29.51B | 24.84B | 21.25B | 18.96B | 16.29B | 13.05B |
| Cost of Revenue | 138.03B | 129.48B | 112.57B | 100.92B | 90.79B | 79.61B | 67.71B | 56.73B | 45.83B | 38.15B | 31.21B | 27.62B | 23.33B | 19.87B | 17.80B | 15.37B | 12.39B |
| Gross Profit | 12.11B | 10.95B | 9.84B | 9.94B | 8.70B | 7.52B | 6.24B | 4.82B | 3.75B | 2.92B | 2.23B | 1.89B | 1.50B | 1.38B | 1.16B | 918.64M | 658.75M |
| Gross Profit Ratio | 8.07% | 7.80% | 8.04% | 8.97% | 8.75% | 8.63% | 8.44% | 7.84% | 7.57% | 7.10% | 6.67% | 6.41% | 6.05% | 6.48% | 6.10% | 5.64% | 5.05% |
| Research & Development | 196.61M | 178.39M | 194.94M | 126.63M | 74.13M | 76.23M | 19.07M | 11.43M | 11.63M | 11.83M | 12.24M | 15.23M | 8.98M | 3.11M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.32B | 828.30M | 800.80M | 636.02M | 588.67M | 532.05M | 493.43M | 348.20M | 287.48M | 200.55M | 145.35M | 108.55M | 85.44M | 66.04M | 311.02M | 247.89M | 170.54M |
| Selling & Marketing | 1.98B | 4.13B | 3.67B | 3.54B | 3.14B | 2.82B | 2.28B | 1.63B | 1.23B | 1.06B | 789.26M | 678.65M | 546.38M | 457.42M | 379.04M | 316.78M | 225.29M |
| SG&A | 7.32B | 4.95B | 4.47B | 4.18B | 3.72B | 3.35B | 2.77B | 1.98B | 1.51B | 1.26B | 934.62M | 787.20M | 631.82M | 523.46M | 690.06M | 564.67M | 395.84M |
| Other Expenses | 1.46B | 1.82B | 1.69B | 1.56B | 1.41B | 4.76M | -20.73M | 62.73M | 96.32M | 112.95M | 94.77M | 60.25M | 140.35M | 33.55M | 20.43M | 9.84M | 5.57M |
| Operating Expenses | 8.98B | 6.95B | 6.36B | 5.86B | 5.21B | 4.82B | 4.02B | 3.03B | 2.38B | 1.89B | 1.40B | 1.19B | 973.87M | 807.58M | 721.28M | 585.40M | 408.29M |
| Cost & Expenses | 147.12B | 136.43B | 118.93B | 106.78B | 96.00B | 84.44B | 71.72B | 59.76B | 48.22B | 40.05B | 32.60B | 28.81B | 24.31B | 20.68B | 18.52B | 15.95B | 12.80B |
| Interest Income | 143.34M | 192.14M | 140.21M | 148.60M | 105.50M | 103.57M | 47.04M | 38.50M | 62.14M | 33.22M | 22.30M | 20.95M | 14.83M | 15.98M | 18.93M | 17.43M | 9.98M |
| Interest Expense | 1.32B | 1.22B | 1.15B | 1.03B | 1.24B | 889.12M | 716.04M | 671.26M | 546.22M | 412.74M | 373.40M | 298.78M | 184.08M | 133.72M | 84.05M | 92.97M | 60.80M |
| Depreciation & Amortization | 774.94M | 782.55M | 703.55M | 556.63M | 536.73M | 436.32M | 372.02M | 303.10M | 220.72M | 161.56M | 148.58M | 128.07M | 103.77M | 90.85M | 65.82M | 47.62M | 38.61M |
| EBITDA | 5.08B | 4.72B | 5.16B | 5.92B | 4.05B | 3.12B | 2.61B | 2.06B | 1.74B | 1.36B | 1.14B | 984.52M | 781.03M | 707.12M | 469.34M | 404.46M | 301.88M |
| EBITDA Ratio | 3.39% | 3.63% | 3.36% | 4.28% | 4.14% | 3.65% | 3.52% | 3.49% | 3.58% | 3.31% | 3.43% | 3.36% | 3.18% | 3.30% | 2.81% | 2.52% | 2.34% |
| Operating Income | 3.02B | 4.36B | 3.59B | 4.35B | 3.63B | 1.83B | 1.94B | 1.05B | 859.98M | 641.54M | 513.31M | 492.81M | 349.99M | 439.25M | 358.08M | 254.70M | 197.15M |
| Operating Income Ratio | 2.01% | 3.10% | 2.93% | 3.93% | 3.64% | 2.10% | 2.63% | 1.70% | 1.73% | 1.56% | 1.54% | 1.67% | 1.41% | 2.07% | 1.89% | 1.56% | 1.51% |
| Total Other Income/Expenses | -31.85M | -1.52B | -229.36M | -18.36M | -1.31B | 847.87K | -16.95M | -594.02M | 95.83M | 111.84M | 93.47M | -138.90M | 136.34M | 33.40M | -49.12M | -61.14M | -42.88M |
| Income Before Tax | 2.99B | 2.84B | 3.36B | 4.33B | 2.32B | 1.83B | 1.92B | 1.11B | 955.81M | 753.38M | 606.78M | 552.45M | 489.65M | 471.98M | 377.55M | 263.87M | 202.47M |
| Income Before Tax Ratio | 1.99% | 2.02% | 2.75% | 3.91% | 2.33% | 2.10% | 2.60% | 1.80% | 1.93% | 1.83% | 1.81% | 1.87% | 1.97% | 2.22% | 1.99% | 1.62% | 1.55% |
| Income Tax Expense | 701.20M | 552.55M | 754.88M | 948.94M | 535.97M | 449.33M | 451.82M | 201.31M | 251.94M | 185.11M | 135.90M | 139.85M | 114.09M | 111.72M | 73.76M | 61.21M | 43.04M |
| Net Income | 2.17B | 2.08B | 2.45B | 3.08B | 1.73B | 1.34B | 1.45B | 876.74M | 694.53M | 560.71M | 477.93M | 412.72M | 374.13M | 353.43M | 297.89M | 202.64M | 159.78M |
| Net Income Ratio | 1.45% | 1.48% | 2.00% | 2.77% | 1.74% | 1.54% | 1.95% | 1.42% | 1.40% | 1.37% | 1.43% | 1.40% | 1.51% | 1.66% | 1.57% | 1.24% | 1.22% |
| EPS | 0.56 | 0.53 | 0.63 | 0.79 | 0.44 | 0.49 | 0.58 | 0.36 | 0.29 | 0.24 | 0.23 | 0.19 | 0.17 | 0.18 | 0.17 | 0.11 | 0.23 |
| EPS Diluted | 0.56 | 0.51 | 0.63 | 0.74 | 0.40 | 0.48 | 0.57 | 0.36 | 0.29 | 0.24 | 0.23 | 0.19 | 0.17 | 0.18 | 0.17 | 0.11 | 0.23 |
| Weighted Avg Shares Out | 3.91B | 3.91B | 3.91B | 3.91B | 3.92B | 2.74B | 2.48B | 2.42B | 2.41B | 2.32B | 2.09B | 2.12B | 2.14B | 1.98B | 1.78B | 1.78B | 700.23M |
| Weighted Avg Shares Out (Dil) | 3.91B | 4.06B | 3.91B | 4.14B | 4.29B | 2.77B | 2.53B | 2.42B | 2.41B | 2.32B | 2.09B | 2.12B | 2.14B | 1.98B | 1.78B | 1.78B | 700.23M |
No news found for: 600998.SS
Source: https://incomestatements.info
Category: Stock Reports